53.08
-0.6449(-1.20%)
Currency In USD
Address
20 Eastbourne Terrace
London, W2 6LG
United Kingdom of Great Britain and Northern Ireland
Phone
44 20 3325 0660
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
2900
First IPO Date
October 19, 2015
| Name | Title | Pay | Year Born |
| Mr. Vladimir A. Makatsaria | Chief Executive Officer & Director | 2.4M | 1973 |
| Mr. Ahmet Tezel Ph.D. | Chief Innovation Officer | 846,059 | N/A |
| Mr. Michael D. Hutchinson | Senior Vice President, Chief Legal Officer & Company Secretary | 995,609 | 1971 |
| Mr. Alex Shvartsburg C.M.A. | Chief Financial Officer | 1.09M | 1970 |
| Mr. Franco Poletti | President of Cardiopulmonary Business Unit | 1.13M | N/A |
| Ms. Lindsey Little | Senior Director of Investor Relations | 0 | N/A |
| Mr. Philip Kowalczyk | Chief Strategy & Corporate Development Officer | 0 | N/A |
| Ms. Natalia Kozmina | Chief Human Resources Officer | 0 | N/A |
| Deanna Wilke | Vice President of Corporate Communications | 0 | N/A |
| Mr. Paul R. Buckman | President of Advanced Circulatory Support & GM of Transcatheter Mitral Valve Replacement | 0 | 1956 |
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products, such as cardiopulmonary and respiratory support solutions. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. It sells its products through direct sales representatives and independent distributors. The company has a research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom.